Risk of inability to collect receivables at a consolidated subsidiary
アクセルメディカ株式会社 (the Company's wholly owned subsidiary)
Loan receivable held by アクセルメディカ株式会社. The name of the business partner and other details have not been disclosed.
The loan remained unpaid after the repayment date of 18 August 2026, and no repayment was made even after multiple payment demands and discussions. The counterparty explained that it did not have sufficient assets or other resources available to repay the debt and was experiencing difficulty making repayment.
¥3 million (the full amount is expected to be recognized as a provision for doubtful accounts or a bad debt loss in the fiscal year ending September 2026)
Fiscal year ending September 2026
¥3 million (the name of the business partner has not been disclosed)
Related procedures
No legal restructuring or other such proceedings have occurred.
Company response
Promptly review and implement the subsidiary's internal procedures for credit decisions and loan execution, its monitoring framework, and measures to prevent recurrence.
The full amount of the receivable is expected to be recognized as a provision for doubtful accounts or a bad debt loss in the fiscal year ending September 2026. Following the dissolution and special liquidation of アクセルメディカ株式会社, revenue from the Beauty & Wellness business is expected to fall temporarily to close to zero until operations resume. The Company will promptly review its internal procedures and monitoring framework and implement measures to prevent recurrence.
| Item | Details |
|---|---|
| Event name | Risk of inability to collect receivables at a consolidated subsidiary |
| Date of occurrence | 17 September 2026 (the date on which the Company determined that there was a risk that the receivable would be uncollectible) |
| Date recognized / date notice received | 17 September 2026 (the date on which the Company determined that there was a risk of non-collection) |
| Subject Entity | アクセルメディカ株式会社 (the Company's wholly owned subsidiary) |
| Target Locations / Products | Loan receivable held by アクセルメディカ株式会社. The name of the business partner and other details have not been disclosed. |
| Cause | The loan remained unpaid after the repayment date of 18 August 2026, and no repayment was made even after multiple payment demands and discussions. The counterparty explained that it did not have sufficient assets or other resources available to repay the debt and was experiencing difficulty making repayment. |
| Amount of Impact on Business Performance | ¥3 million (the full amount is expected to be recognized as a provision for doubtful accounts or a bad debt loss in the fiscal year ending September 2026) |
| Accounting period in which recognized | Fiscal year ending September 2026 |
| Type of litigation or proceeding | No legal restructuring or other such proceedings have occurred. |
| Amount of receivables at risk of non-collection or delayed collection | ¥3 million (the name of the business partner has not been disclosed) |
| Measures to prevent recurrence | Promptly review and implement the subsidiary's internal procedures for credit decisions and loan execution, its monitoring framework, and measures to prevent recurrence. |
| Outlook | The full amount of the receivable is expected to be recognized as a provision for doubtful accounts or a bad debt loss in the fiscal year ending September 2026. Following the dissolution and special liquidation of アクセルメディカ株式会社, revenue from the Beauty & Wellness business is expected to fall temporarily to close to zero until operations resume. The Company will promptly review its internal procedures and monitoring framework and implement measures to prevent recurrence. |
Items this document does not state (13)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The loan remained unpaid after the repayment date of 18 August 2026, and no repayment was made even after multiple payment demands and discussions. The counterparty explained that it did not have sufficient assets or other resources available to repay the debt and was experiencing difficulty making repayment.